How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,161 results for

Hypertrichosis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. A randomized double blind, vehicle controlled bilateral comparison study of the efficacy and safety of finasteride 0.5% solution in combination with intense pulsed light in the treatment of facial hirsutism. (Abstract)

A randomized double blind, vehicle controlled bilateral comparison study of the efficacy and safety of finasteride 0.5% solution in combination with intense pulsed light in the treatment of facial hirsutism. We sought to determine whether topical finasteride can enhance the efficacy of intense pulsed light hair removal.An intense pulsed light (IPL) treatment with radiofrequency (RF) was performed every four weeks, resulting in up to three sessions, and again at the end of the study - 6 months

2012 Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology Controlled trial quality: uncertain

82. ROUTINE SCREENING FOR CUSHING'S SYNDROME IS NOT REQUIRED IN PATIENTS PRESENTING WITH HIRSUTISM. Full Text available with Trip Pro

ROUTINE SCREENING FOR CUSHING'S SYNDROME IS NOT REQUIRED IN PATIENTS PRESENTING WITH HIRSUTISM. Prevalence of Cushing's syndrome (CS) in patients presenting with hirsutism is not well known.Screening of CS in patients with hirsutism.Referral hospital.This study was carried out on 105 patients who were admitted to the Endocrinology Department with the complaint of hirsutism.All the patients were evaluated with low-dose dexamethasone suppression test (LDDST) for CS.Response to LDDST in patients (...) presenting with hirsutism.All the patients had suppressed cortisol levels following low-dose dexamethasone administration excluding CS. The etiology of hirsutism was polycystic ovary syndrome in 79%, idiopathic hirsutism in 13%, idiopathic hyperandrogenemia in 6%, and nonclassical congenital hyperplasia in 2% of the patients.Routine screening for CS in patients with a referral diagnosis of hirsutism is not required. For the time being, diagnostic tests for CS in hirsute patients should be limited

2012 European Journal of Endocrinology

83. Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism. (Abstract)

Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism. Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting reproductive-age women and is reported to be associated with an increased risk of cardiovascular disease and early atherosclerosis. Epicardial fat thickness (EF) is clinically related to subclinical atherosclerosis and visceral fat changes (...) . Therefore, the objective of this study is to compare the carotid artery intima-media thickness (CIMT), EF and cardiometabolic risk factors in patients with PCOS, patients with idiopathic hirsutism (IH) and healthy controls.This cross-sectional controlled study was conducted in a training and research hospital. The study population consisted of 50 reproductive-age PCOS women, 34 women with IH and 39 control subjects. We evaluated anthropometric, hormonal and metabolic parameters as well as CIMT and EF

2012 Atherosclerosis

84. The investigation and management of hirsutism. Full Text available with Trip Pro

The investigation and management of hirsutism. Excess male-pattern body hair in women is a very common and psychologically damaging condition. Although its cause is usually a chronic and benign disorder (most commonly polycystic ovary syndrome) it may rarely be an indication of a more serious endocrine disease such as Cushing syndrome or an androgen-secreting tumour. Investigations do not usually need to be extensive, but effective management is important, irrespective of cause, for what can

2012 Journal of Family Planning and Reproductive Health Care

85. An approach to the patient with hirsutism. Full Text available with Trip Pro

An approach to the patient with hirsutism. Hirsutism is a common endocrinological complaint. The causes of this complaint can vary from dissatisfaction with a normal pattern of hair growth on the one hand, to the first clinical manifestation of androgen overproduction by an adrenal adenocarcinoma on the other. The purpose of this short review is to reexamine the physiology of hair growth in normal women, identify the common abnormal patterns, and explore the differential diagnosis associated (...) with each. An approach to working through the differential diagnosis will be described, and the commonly available treatment modalities for the various forms of hirsutism will be examined in terms of risk and benefit. The review is written from the point of view of the physician and the most efficient, cost effective, and safe clinical approach to the patient with the problem.

2012 Journal of Clinical Endocrinology and Metabolism

86. Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens. (Abstract)

Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens. To compare the effectiveness of three different combinations of combined oral contraceptives (COCs) and anti-androgens in the treatment of hirsutism.A total of 134 women with moderate and severe hirsutism were randomly assigned to three treatment regimens: Group I received 30 μg of ethinyl estradiol (EE)/3 mg (...) of drospirenone (DRSP) plus 100 mg of cyproterone acetate (CPA) (n = 45); group II received 30 μg of EE/3 mg of DRSP plus 100 mg of spironolactone (n = 44); and group III received 35 μg of EE/2 mg of CPA plus 100 mg of CPA (n = 45), daily for 6 months. The decrease in the modified Ferriman-Gallwey hirsutism score (mFGS) was the main outcome measure.The mean decrease in mFGS after 3 and 6 months of the treatment course was 26% and 49% in group I (both p < 0.01), 27% and 49% in group II (both p < 0.01), and 25

2012 Journal of Dermatological Treatment Controlled trial quality: uncertain

87. The Excretion of Pregnanediol and 17-Ketosteroids during the Menstrual Cycle in Benign Hirsutism Full Text available with Trip Pro

The Excretion of Pregnanediol and 17-Ketosteroids during the Menstrual Cycle in Benign Hirsutism 16810911 2006 07 03 2018 12 01 0021-9746 4 1 1951 Feb Journal of clinical pathology J. Clin. Pathol. The Excretion of Pregnanediol and 17-Ketosteroids during the Menstrual Cycle in Benign Hirsutism. 78-84 Merivale W H WH Department of Clinical Pathology, Guy's Hospital, London. eng Journal Article England J Clin Pathol 0376601 0021-9746 0 17-Ketosteroids 0 Androgens 0 Progestins JR3JD1Y22C (...) Pregnanediol OM 17-Ketosteroids Androgens Female Hair Hirsutism Humans Menstrual Cycle Menstruation Pregnanediol Progestins 5120:56455:31:37:188:407 ANDROGENS HAIR MENSTRUATION PREGNANDIOL 1951 2 1 0 0 1951 2 1 0 1 1951 2 1 0 0 ppublish 16810911 PMC1023360 Biochem J. 1948;42(3):366-71 16748295 J Clin Invest. 1941 Jan;20(1):21-30 16694804 Biochem J. 1950 Mar;46(3):290-6 16748678 Science. 1944 Jul 21;100(2586):58-60 17758923

1951 Journal of Clinical Pathology

88. Adrenocortical Hyperfunction associated with Hirsutism, Obesity, Hypertension and Normal Glucocorticoid Secretion Full Text available with Trip Pro

Adrenocortical Hyperfunction associated with Hirsutism, Obesity, Hypertension and Normal Glucocorticoid Secretion 14371597 2003 05 01 2018 12 01 0035-9157 48 4 1955 Apr Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Adrenocortical hyperfunction associated with hirsutism, obesity, hypertension and normal glucocorticoid secretion. 316-8 GARROD O O KELLIE A E AE eng Journal Article England Proc R Soc Med 7505890 0035-9157 OM Adrenal Cortex Adrenal Cortex Diseases Adrenocortical (...) Hyperfunction Hair Hair Diseases Hirsutism Humans Hypertension etiology Obesity etiology 5528:22442:14:253:285:399 ADRENAL CORTEX/diseases HAIR/diseases HYPERTENSION/etiology and pathogenesis OBESITY/etiology and pathogenesis 1955 4 1 1955 4 1 0 1 1955 4 1 0 0 ppublish 14371597 PMC1918762 Am J Med. 1954 Mar;16(3):340-5 13138605 N Engl J Med. 1954 Aug 19;251(8):293-7 13185417

1955 Proceedings of the Royal Society of Medicine

89. Adrenocortical Hyperfunction in “Idiopathic” Hirsutism and the Stein-Leventhal Syndrome Full Text available with Trip Pro

Adrenocortical Hyperfunction in “Idiopathic” Hirsutism and the Stein-Leventhal Syndrome 13549590 2000 07 01 2018 12 01 0021-9738 37 6 1958 Jun The Journal of clinical investigation J. Clin. Invest. Adrenocortical hyperfunction in idiopathic hirsutism and the Stein-Leventhal syndrome. 794-9 GALLAGHER T F TF KAPPAS A A HELLMAN L L LIPSETT M B MB PEARSON O H OH WEST C D CD eng Journal Article United States J Clin Invest 7802877 0021-9738 0 Adrenal Cortex Hormones OM Adrenal Cortex Hormones (...) Adrenocortical Hyperfunction Female Hair Hirsutism Humans Polycystic Ovary Syndrome complications 5834:42237:14:257:564 ADRENAL CORTEX HORMONES HAIR STEIN-LEVENTHAL SYNDROME/complications 1958 6 1 1958 6 1 0 1 1958 6 1 0 0 ppublish 13549590 10.1172/JCI103666 PMC1062735 Endocrinology. 1950 Jan;46(1):127-31 15405788 J Biol Chem. 1957 Nov;229(1):505-18 13491600 Gynaecologia. 1954 Aug;138(2):276-87 13200907 J Biol Chem. 1954 Feb;206(2):863-74 13143048 AMA Arch Intern Med. 1957 Dec;100(6):981-5 13478206 J Clin

1958 Journal of Clinical Investigation

90. Development of Hirsutism after Puberty Full Text available with Trip Pro

Development of Hirsutism after Puberty 13608046 2000 07 01 2018 12 01 0007-1447 2 5112 1958 Dec 27 British medical journal Br Med J Development of hirsutism after puberty. 1554-7 PRUNTY F T FT BROOKS R V RV MATTINGLY D D eng Journal Article England Br Med J 0372673 0007-1447 OM Diagnosis, Differential Female Hair Hirsutism Humans Polycystic Ovary Syndrome diagnosis Puberty Sexual Maturation 5935:37693:250:556 HAIR STEIN-LEVENTHAL SYNDROME/differential diagnosis 1958 12 27 1958 12 27 0 1 1958 12

1958 British medical journal

91. Discussion on Amenorrhœa and Hirsutism Full Text available with Trip Pro

Discussion on Amenorrhœa and Hirsutism 13453429 2002 05 01 2018 12 01 0035-9157 50 6 1957 Jun Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Discussion on amenorrhoea and hirsutism. 453-60 REY J H JH DONOVAN B T BT THOMAS P K PK FERRIMAN D D BISHOP P M PM DEVERE R D RD eng Journal Article England Proc R Soc Med 7505890 0035-9157 OM Amenorrhea physiology Female Hair Hirsutism Humans 5732:51760 AMENORRHEA/physiology HAIR 1957 6 1 1957 6 1 0 1 1957 6 1 0 0 ppublish 13453429

1957 Proceedings of the Royal Society of Medicine

92. Alopecia totalis supervening on Hirsutism Full Text available with Trip Pro

Alopecia totalis supervening on Hirsutism 19990133 2010 06 24 2010 06 24 0035-9157 28 4 1935 Feb Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Alopecia totalis supervening on Hirsutism. 369-70 Macbeth A N AN eng Journal Article England Proc R Soc Med 7505890 0035-9157 2009 12 9 6 0 1935 2 1 0 0 1935 2 1 0 1 ppublish 19990133 PMC2205306

1935 Proceedings of the Royal Society of Medicine

93. Obesity and Hirsutes of ? Adrenal Origin Full Text available with Trip Pro

Obesity and Hirsutes of ? Adrenal Origin 19988653 2010 06 24 2010 06 24 0035-9157 25 5 1932 Mar Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Obesity and Hirsutes of ? Adrenal Origin. 722-4 Ellis R W RW eng Journal Article England Proc R Soc Med 7505890 0035-9157 2009 12 9 6 0 1932 3 1 0 0 1932 3 1 0 1 ppublish 19988653 PMC2183654

1932 Proceedings of the Royal Society of Medicine

94. Raised serum prolactin levels associated with hirsutism and amenorrhoea. Full Text available with Trip Pro

Raised serum prolactin levels associated with hirsutism and amenorrhoea. 1191969 1976 02 19 2018 11 13 0007-1447 4 5989 1975 Oct 18 British medical journal Br Med J Raised serum prolactin levels associated with hirsutism and amenorrhoea. 144-5 Seppälä M M Hirvonen E E eng Journal Article England Br Med J 0372673 0007-1447 9002-62-4 Prolactin AIM IM Amenorrhea blood Female Galactorrhea blood Hirsutism blood Humans Pregnancy Prolactin blood 1975 10 18 1975 10 18 0 1 1975 10 18 0 0 ppublish

1975 British medical journal

95. Hirsutism Full Text available with Trip Pro

Hirsutism 1197153 1976 02 09 2018 11 13 0032-5473 51 594 1975 Apr Postgraduate medical journal Postgrad Med J Hirsutism. 236-9 London D R DR eng Journal Article England Postgrad Med J 0234135 0032-5473 0 Androgens IM Adrenal Glands physiopathology Androgens biosynthesis metabolism Female Hirsutism etiology physiopathology therapy Humans Ovary physiopathology 1975 4 1 1975 4 1 0 1 1975 4 1 0 0 ppublish 1197153 PMC2495956 J Clin Endocrinol Metab. 1970 Apr;30(4):435-42 5435284 J Clin Endocrinol

1975 Postgraduate medical journal

96. Urinary testosterone response to corticotrophin and dexamethasone in hirsute women. Full Text available with Trip Pro

Urinary testosterone response to corticotrophin and dexamethasone in hirsute women. 4375288 1975 05 13 2018 11 13 0035-9157 67 12 Pt 1 1974 Dec Proceedings of the Royal Society of Medicine Proc. R. Soc. Med. Urinary testosterone response to corticotrophin and dexamethasone in hirsute women. 1223 Leigh R J RJ Feetwood J A JA Hall R R eng Journal Article England Proc R Soc Med 7505890 0035-9157 3XMK78S47O Testosterone 7S5I7G3JQL Dexamethasone 9002-60-2 Adrenocorticotropic Hormone IM Adolescent (...) Adrenocorticotropic Hormone pharmacology Adult Dexamethasone pharmacology Female Hirsutism urine Humans Testosterone urine 1974 12 1 1974 12 1 0 1 1974 12 1 0 0 ppublish 4375288 PMC1645865 Biochem J. 1966 Jun;99(3):717-25 5964968 Clin Endocrinol (Oxf). 1974 Oct;3(4):457-63 4372002

1974 Proceedings of the Royal Society of Medicine

97. Hirsutism and anovulatory infertility. Full Text available with Trip Pro

Hirsutism and anovulatory infertility. 5014972 1972 06 03 2018 11 13 0032-5473 48 555 1972 Jan Postgraduate medical journal Postgrad Med J Hirsutism and anovulatory infertility. 14-9 Brooks R V RV eng Journal Article England Postgrad Med J 0234135 0032-5473 0 17-Ketosteroids 0 Androgens 0 Estrogens 3XMK78S47O Testosterone WI4X0X7BPJ Hydrocortisone IM 17-Ketosteroids urine Adrenal Gland Neoplasms complications Androgens biosynthesis Cushing Syndrome complications Estrogens biosynthesis Female (...) Hirsutism etiology Humans Hydrocortisone biosynthesis Infertility, Female complications Ovarian Cysts complications Ovarian Neoplasms complications Testosterone metabolism 1972 1 1 1972 1 1 0 1 1972 1 1 0 0 ppublish 5014972 PMC2495191 Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):911-4 4220829 J Clin Endocrinol Metab. 1968 Apr;28(4):479-84 5643867 J Clin Endocrinol Metab. 1962 Mar;22:325-38 13899931 Recent Prog Horm Res. 1964;20:341-94 14285041 J Clin Endocrinol Metab. 1966 Nov;26(11):1267-9 5924286 J Clin

1972 Postgraduate medical journal

98. Hirsutes. Full Text available with Trip Pro

Hirsutes. 5572389 1971 06 19 2013 11 21 0007-1447 2 5756 1971 May 01 British medical journal Br Med J Hirsutes. 264-6 Besser G M GM Witt M M eng Journal Article England Br Med J 0372673 0007-1447 0 17-Ketosteroids 3XMK78S47O Testosterone AIM IM 17-Ketosteroids blood Cushing Syndrome Female Hirsutism etiology therapy Humans Hyperplasia Ovarian Cysts complications Ovarian Neoplasms complications Ovary drug effects physiopathology Ovulation Testosterone blood Virilism 1971 5 1 1971 5 1 0 1 1971 5

1971 British medical journal

99. Editorial: endocrine treatment hirsutism. Full Text available with Trip Pro

Editorial: endocrine treatment hirsutism. 1148657 1975 11 08 2018 11 13 0007-1447 2 5969 1975 May 31 British medical journal Br Med J Editorial: endocrine treatment hirsutism. 461 eng Journal Article England Br Med J 0372673 0007-1447 0 Contraceptives, Oral 0 Contraceptives, Oral, Hormonal 0 Estrogens 0 Glucocorticoids 3XMK78S47O Testosterone 7S5I7G3JQL Dexamethasone E61Q31EK2F Cyproterone AIM IM Adrenal Glands drug effects Contraceptives, Oral therapeutic use Contraceptives, Oral, Hormonal (...) therapeutic use Cyproterone adverse effects therapeutic use Dexamethasone therapeutic use Estrogens pharmacology Female Glucocorticoids therapeutic use Hirsutism drug therapy Humans Testosterone metabolism 1975 5 31 1975 5 31 0 1 1975 5 31 0 0 ppublish 1148657 PMC1673438 Am J Med. 1973 Feb;54(2):195-200 4346681 Clin Endocrinol (Oxf). 1975 Jan;4(1):65-73 1122656

1975 British medical journal

100. The Hirsute Patient Full Text available with Trip Pro

The Hirsute Patient 18730960 2010 06 28 2018 11 13 0008-1264 119 1 1973 Jul California medicine Calif Med The hirsute patient. 60 Mishell D R DR eng Journal Article United States Calif Med 0410260 0008-1264 1973 7 1 0 0 1973 7 1 0 1 1973 7 1 0 0 ppublish 18730960 PMC1455387 Calif Med. 1967 Feb;106(2):87-91 6044295 Ann Intern Med. 1972 Jun;76(6):899-910 5027583 N Engl J Med. 1965 Sep 9;273:602-4 CONTD 14329633

1973 California Medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>